Literature DB >> 8909550

Developmental expression and distinctive tyrosine phosphorylation of the Eph-related receptor tyrosine kinase Cek9.

C Soans1, J A Holash, Y Pavlova, E B Pasquale.   

Abstract

Cek9 is a receptor tyrosine kinase of the Eph subfamily for which only a partial cDNA sequence was known (Sajjadi, F.G., and E.B. Pasquale. 1993. Oncogene. 8:1807-1813). We have obtained the entire cDNA sequence and identified a variant form of Cek9 that lacks a signal peptide. We subsequently examined the spatio-temporal expression and tyrosine phosphorylation of Cek9 in the chicken embryo by using specific antibodies. At embryonic day 2, Cek9 immunoreactivity is concentrated in the eye, the brain, the posterior region of the neural tube, and the most recently formed somites. Later in development, Cek9 expression is widespread but particularly prominent in neural tissues. In the developing visual system, Cek9 is highly concentrated in areas containing retinal ganglion cell axons, suggesting a role in regulating their outgrowth to the optic tectum. Unlike other Eph-related receptors, Cek9 is substantially phosphorylated on tyrosine in many tissues at various developmental stages. Since autophosphorylation of receptor protein-tyrosine kinases typically correlates with increased enzymatic activity, this suggests that Cek9 plays an active role in embryonic signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909550      PMCID: PMC2121056          DOI: 10.1083/jcb.135.3.781

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.

Authors:  B D Bennett; F C Zeigler; Q Gu; B Fendly; A D Goddard; N Gillett; W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

2.  An alternative to SH2 domains for binding tyrosine-phosphorylated proteins.

Authors:  W M Kavanaugh; L T Williams
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

3.  cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases.

Authors:  G M Fox; P L Holst; H T Chute; R A Lindberg; A M Janssen; R Basu; A A Welcher
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

Review 4.  Receptor protein-tyrosine kinases and their signal transduction pathways.

Authors:  P van der Geer; T Hunter; R A Lindberg
Journal:  Annu Rev Cell Biol       Date:  1994

5.  B61 is a ligand for the ECK receptor protein-tyrosine kinase.

Authors:  T D Bartley; R W Hunt; A A Welcher; W J Boyle; V P Parker; R A Lindberg; H S Lu; A M Colombero; R L Elliott; B A Guthrie
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

6.  Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity.

Authors:  S Davis; N W Gale; T H Aldrich; P C Maisonpierre; V Lhotak; T Pawson; M Goldfarb; G D Yancopoulos
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

7.  Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity.

Authors:  A Pandey; D F Lazar; A R Saltiel; V M Dixit
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

8.  Several receptor tyrosine kinase genes of the Eph family are segmentally expressed in the developing hindbrain.

Authors:  N Becker; T Seitanidou; P Murphy; M G Mattéi; P Topilko; M A Nieto; D G Wilkinson; P Charnay; P Gilardi-Hebenstreit
Journal:  Mech Dev       Date:  1994-07       Impact factor: 1.882

9.  Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

Authors:  A Pandey; H Shao; R M Marks; P J Polverini; V M Dixit
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

10.  A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors.

Authors:  P Blaikie; D Immanuel; J Wu; N Li; V Yajnik; B Margolis
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.